Media

Media Contact National Headquarters Walmart & FAACT Take the Fear Out of Halloween Fun! FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® (Intranasal Epinephrine) Pulmonary-Allergy Drugs Advisory Committee Meeting DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut FAACT Partners with MenuTrinfo® FAACT Is Learning to Live in Empathy A Statement from the Food Allergy & Anaphylaxis Connection Team about Racism, Food Allergy Disparities, and Health Inequities FAACT, ACAAI, NPB Partner on Early Intro to Peanut Vitality Bowls Rallies Communities in Support of Food Allergy Awareness Global Parenting Expert, Jo Frost, Announced as National Spokesperson for FAACT and Will Raise Awareness Around Food Allergies FAACT CEO Hosts Healthline’s Patient Roundtable: Living with Severe Allergies New FAACT and ACAAI Campaign Seeks to Close the Gap on Food Allergy Diagnosis and Management Awareness FAACT CEO Inducted into NAPW VIP Professional Woman of the Year Circle FAACT CEO Named Among The 15 Most Imporant Moms In the Food Industry FAACT Reaches Clawson Public Schools in Michigan

FAACT CEO Hosts Healthline’s Patient Roundtable: Living with Severe Allergies

FAACT CEO, Eleanor Garrow-Holding, visited Healthline in San Francisco to host their patient roundtable discussing severe allergies and anaphylaxis. The discussion included emergency procedures, epinephrine auto-injectors, and tips for avoiding known allergens with fellow food allergy advocates. There were many resources and tips offered during this discussion. Whether you are a newly diagnosed family, sending your child to school, or living with food allergies as an adult – this discussion is for you. Click here to view the patient roundtable discussion.